Pharmaceutical Executive

Official Twitter account for Pharmaceutical Executive, a digital and print magazine offering news and opinions, analysis, features and executive profiles.

[Pharmaceutical Executive @PharmExec]

🚨Our March issue is LIVE🚨
Learn about immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics in our cover profile🔷 Sourcing, nurturing, and retaining talent🔷Making HCP analytics actually work for commercial teams🔷and much more right here➡️https://t.co/OhroSxYKFH

[Pharmaceutical Executive @PharmExec]

Relocating a lab (or just one instrument) doesn't have to mean lost time. Agilent CrossLab shares how to move smart & stay compliant.

🔧 See how: https://t.co/sFeACEbYCS

[Pharmaceutical Executive @PharmExec]

“Efficacy is no longer the biggest unmet need in obesity treatment.”

Corxel’s Dr. Bo Liang points to GI side effects, convenience, lean mass loss & weight regain as what’s next for drug development.

Watch more here➡️ https://t.co/IERZl90WxD

#PharmaExecutive #ObesityTreatment

[Pharmaceutical Executive @PharmExec]

Hansoh Pharma & Roche just expanded their ADC partnership.

Up to $15B in milestones, $400M upfront, plus tiered royalties on a broad portfolio of antibody-drug conjugates.

Full deal here ➡️ https://t.co/JaFu1fryCd

#ADC #Oncology

[Pharmaceutical Executive @PharmExec]

Self-reported data accuracy, not volume, is clinical trial enrollment’s costliest problem.

Jen Lampa of Inovalon says documented patient history is the more reliable check.

📽️ Watch the clip: https://t.co/7eadOs2X0g

#PharmExec #ClinicalTrials

[Pharmaceutical Executive @PharmExec]

Nine episodes, one question: how does pharma lead through pricing pressure, tariffs, onshoring & AI at the FDA?
Catch up on the full Fault Lines Peer Exchange series: https://t.co/l8XyUdbK3c
#PharmaExec

[Pharmaceutical Executive @PharmExec]

Precision medicine is shifting from targeting a disease to matching treatment to a patient’s exact biology.

RNA editing and AI are closing the gap between insight and real therapies.

🔒Unlock the feature: https://t.co/0D5nNZ2OhQ

#PharmExec #PrecisionMedicine

[Pharmaceutical Executive @PharmExec]

Biotech's biggest threat right now isn't the market, it's eroding trust.

Jeremy Levin (Ovid Therapeutics, ex-Teva CEO) says real leadership takes accountability and action, not just messaging.

🎙️ Hear his case for rebuilding trust: https://t.co/gsguhayBD4

#PharmExec #Biotech

[Pharmaceutical Executive @PharmExec]

Employer healthcare costs keep climbing, and consolidation is the biggest reason why.

Michael Abrams of Numerof & Associates says provider market power & incentives for more costly care are driving the increase, with no clear end in sight.

Watch more here ➡️ https://t.co/pkxtBHFbWO

#PharmExec #HealthcareCosts

[Pharmaceutical Executive @PharmExec]

A negotiated price only matters if it reaches the pharmacy counter correctly. MFP effectuation spans manufacturer, pharmacy and Part D plan workflows, and each handoff carries risk. Learn how to stay audit-ready.

Register now: https://t.co/t65HdlCTi8

[Pharmaceutical Executive @PharmExec]

Scaling a pharma or biotech business comes down to one thing: talent.

Elaine Ferguson of Inizio Medical breaks down why connecting & developing talent drives sustainable growth.

Hear more here ➡️ https://t.co/6yRd1yvs7D

#Leadership #TalentDevelopment

[Pharmaceutical Executive @PharmExec]

AI is reshaping drug development & how FDA reviews it. The final Fault Lines Peer Exchange closes with what pharma boards need to know next: https://t.co/n9SS8L0i80

#PharmaExec

[Pharmaceutical Executive @PharmExec]

The FDA's peptide rulemaking is stalling.

An advisory panel already recommended 6 peptides for compounding, but enforcement is already cracking down on unapproved sellers.

Free sign-up, then read more here ➡️ https://t.co/4Fp7Z9snSr

#PharmExec #peptides #compounding

[Pharmaceutical Executive @PharmExec]

Our 2026 Emerging Pharma Leaders were in the studio this week, filming a Peer Exchange with Pharmaceutical Executive.

Congrats to Sarah Ghosh, Nick Botwood, Rena Denoncourt, Christopher Savage & Abid Rahman!

Stay tuned for the full conversation!

#EmergingPharmaLeaders #PharmExec

[Pharmaceutical Executive @PharmExec]

MFPs are now in effect, and manufacturers have little time to get effectuation right. Get practical guidance on MFP compliance, drawn from direct engagement with CMS.

Register now: https://t.co/Kr6bxAODTS

[Pharmaceutical Executive @PharmExec]

As therapies move from the clinic to the home, patient confidence is critical to success. Discover how human factors, training, and ongoing support can help drive long-term adherence. #PatientSupport
https://t.co/3idN3sy1jG

[Pharmaceutical Executive @PharmExec]

China's biotech licensing deals hit $51.9 billion in 2024, up 90% year over year.

Dr. Ying Huang, CEO of K2 Therapeutics, on what's fueling the shift.

🔗 Watch more: https://t.co/GJUrS2qNny

#PharmExec #Biotech

[Pharmaceutical Executive @PharmExec]

Agentic AI is reshaping the specialty pharmacy experience. Explore how Gifthealth combines intelligent automation with human expertise to streamline the prescription journey while keeping empathy, clinical judgment, and trust at the center. #HealthTech
https://t.co/Whh5SUZomX

[Pharmaceutical Executive @PharmExec]

As specialty therapies become more complex, patient support must evolve beyond individual services. Discover how connected technology and human engagement can create a more coordinated, personalized patient experience. #PatientSupport
https://t.co/ILaeK56xNB

[Pharmaceutical Executive @PharmExec]

An executive order can cut drug prices today & get undone tomorrow.

Joe Cunningham says the new MFN deals are a good first step, but without Congress behind them, they only touch Medicaid, leaving the commercial market, about 80% of Americans, untouched.

#PharmExec #DrugPricing

[Pharmaceutical Executive @PharmExec]

Onshoring pledges & a shifting FDA pricing conversation are reshaping how pharma leaders plan ahead.

Latest Fault Lines Peer Exchange: https://t.co/rV0ad0ccVd
#PharmaExec